The global market for Neuropathic Eye Pain was valued at US$ 161 million in the year 2024 and is projected to reach a revised size of US$ 200 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Neuropathic Eye Pain Market

North American market for Neuropathic Eye Pain is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Neuropathic Eye Pain is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Neuropathic Eye Pain in Clinic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Neuropathic Eye Pain include OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Neuropathic Eye Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Eye Pain.

The Neuropathic Eye Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuropathic Eye Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuropathic Eye Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neuropathic Eye Pain Market Report

Report Metric	Details
Report Name	Neuropathic Eye Pain Market
Accounted market size in year	US$ 161 million
Forecasted market size in 2031	US$ 200 million
CAGR	3.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Steroids Antidepressants Anticonvulsants Opioids Others
Segment by Application	Clinic Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, AlconLaboratories, BRIM Biotechnology Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathic Eye Pain company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neuropathic Eye Pain Market growing?

Ans: The Neuropathic Eye Pain Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Neuropathic Eye Pain Market size in 2031?

Ans: The Neuropathic Eye Pain Market size in 2031 will be US$ 200 million.

Who are the main players in the Neuropathic Eye Pain Market report?

Ans: The main players in the Neuropathic Eye Pain Market are OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, AlconLaboratories, BRIM Biotechnology Inc

What are the Application segmentation covered in the Neuropathic Eye Pain Market report?

Ans: The Applications covered in the Neuropathic Eye Pain Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Neuropathic Eye Pain Market report?

Ans: The Types covered in the Neuropathic Eye Pain Market report are Steroids, Antidepressants, Anticonvulsants, Opioids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuropathic Eye Pain Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Steroids

1.2.3 Antidepressants

1.2.4 Anticonvulsants

1.2.5 Opioids

1.2.6 Others

1.3 Market by Application

1.3.1 Global Neuropathic Eye Pain Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuropathic Eye Pain Market Perspective (2020-2031)

2.2 Global Neuropathic Eye Pain Growth Trends by Region

2.2.1 Global Neuropathic Eye Pain Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neuropathic Eye Pain Historic Market Size by Region (2020-2025)

2.2.3 Neuropathic Eye Pain Forecasted Market Size by Region (2026-2031)

2.3 Neuropathic Eye Pain Market Dynamics

2.3.1 Neuropathic Eye Pain Industry Trends

2.3.2 Neuropathic Eye Pain Market Drivers

2.3.3 Neuropathic Eye Pain Market Challenges

2.3.4 Neuropathic Eye Pain Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neuropathic Eye Pain Players by Revenue

3.1.1 Global Top Neuropathic Eye Pain Players by Revenue (2020-2025)

3.1.2 Global Neuropathic Eye Pain Revenue Market Share by Players (2020-2025)

3.2 Global Neuropathic Eye Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neuropathic Eye Pain Revenue

3.4 Global Neuropathic Eye Pain Market Concentration Ratio

3.4.1 Global Neuropathic Eye Pain Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Eye Pain Revenue in 2024

3.5 Global Key Players of Neuropathic Eye Pain Head office and Area Served

3.6 Global Key Players of Neuropathic Eye Pain, Product and Application

3.7 Global Key Players of Neuropathic Eye Pain, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropathic Eye Pain Breakdown Data by Type

4.1 Global Neuropathic Eye Pain Historic Market Size by Type (2020-2025)

4.2 Global Neuropathic Eye Pain Forecasted Market Size by Type (2026-2031)

5 Neuropathic Eye Pain Breakdown Data by Application

5.1 Global Neuropathic Eye Pain Historic Market Size by Application (2020-2025)

5.2 Global Neuropathic Eye Pain Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neuropathic Eye Pain Market Size (2020-2031)

6.2 North America Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neuropathic Eye Pain Market Size by Country (2020-2025)

6.4 North America Neuropathic Eye Pain Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neuropathic Eye Pain Market Size (2020-2031)

7.2 Europe Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neuropathic Eye Pain Market Size by Country (2020-2025)

7.4 Europe Neuropathic Eye Pain Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neuropathic Eye Pain Market Size (2020-2031)

8.2 Asia-Pacific Neuropathic Eye Pain Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2020-2025)

8.4 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neuropathic Eye Pain Market Size (2020-2031)

9.2 Latin America Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neuropathic Eye Pain Market Size by Country (2020-2025)

9.4 Latin America Neuropathic Eye Pain Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neuropathic Eye Pain Market Size (2020-2031)

10.2 Middle East & Africa Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2020-2025)

10.4 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 OKYO Pharma

11.1.1 OKYO Pharma Company Details

11.1.2 OKYO Pharma Business Overview

11.1.3 OKYO Pharma Neuropathic Eye Pain Introduction

11.1.4 OKYO Pharma Revenue in Neuropathic Eye Pain Business (2020-2025)

11.1.5 OKYO Pharma Recent Development

11.2 Ocular Therapeutix, Inc.

11.2.1 Ocular Therapeutix, Inc. Company Details

11.2.2 Ocular Therapeutix, Inc. Business Overview

11.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Introduction

11.2.4 Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025)

11.2.5 Ocular Therapeutix, Inc. Recent Development

11.3 IACTA Pharmaceuticals, Inc.

11.3.1 IACTA Pharmaceuticals, Inc. Company Details

11.3.2 IACTA Pharmaceuticals, Inc. Business Overview

11.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Introduction

11.3.4 IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025)

11.3.5 IACTA Pharmaceuticals, Inc. Recent Development

11.4 Sun Pharmaceutical Industries Ltd

11.4.1 Sun Pharmaceutical Industries Ltd Company Details

11.4.2 Sun Pharmaceutical Industries Ltd Business Overview

11.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Introduction

11.4.4 Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2020-2025)

11.4.5 Sun Pharmaceutical Industries Ltd Recent Development

11.5 Novartis AG

11.5.1 Novartis AG Company Details

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Neuropathic Eye Pain Introduction

11.5.4 Novartis AG Revenue in Neuropathic Eye Pain Business (2020-2025)

11.5.5 Novartis AG Recent Development

11.6 SALVAT

11.6.1 SALVAT Company Details

11.6.2 SALVAT Business Overview

11.6.3 SALVAT Neuropathic Eye Pain Introduction

11.6.4 SALVAT Revenue in Neuropathic Eye Pain Business (2020-2025)

11.6.5 SALVAT Recent Development

11.7 AbbVie Inc

11.7.1 AbbVie Inc Company Details

11.7.2 AbbVie Inc Business Overview

11.7.3 AbbVie Inc Neuropathic Eye Pain Introduction

11.7.4 AbbVie Inc Revenue in Neuropathic Eye Pain Business (2020-2025)

11.7.5 AbbVie Inc Recent Development

11.8 Bausch &Lomb Incorporated

11.8.1 Bausch &Lomb Incorporated Company Details

11.8.2 Bausch &Lomb Incorporated Business Overview

11.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Introduction

11.8.4 Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2020-2025)

11.8.5 Bausch &Lomb Incorporated Recent Development

11.9 Kala Pharmaceuticals

11.9.1 Kala Pharmaceuticals Company Details

11.9.2 Kala Pharmaceuticals Business Overview

11.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Introduction

11.9.4 Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2020-2025)

11.9.5 Kala Pharmaceuticals Recent Development

11.10 Spectra Vision Care

11.10.1 Spectra Vision Care Company Details

11.10.2 Spectra Vision Care Business Overview

11.10.3 Spectra Vision Care Neuropathic Eye Pain Introduction

11.10.4 Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2020-2025)

11.10.5 Spectra Vision Care Recent Development

11.11 AlconLaboratories

11.11.1 AlconLaboratories Company Details

11.11.2 AlconLaboratories Business Overview

11.11.3 AlconLaboratories Neuropathic Eye Pain Introduction

11.11.4 AlconLaboratories Revenue in Neuropathic Eye Pain Business (2020-2025)

11.11.5 AlconLaboratories Recent Development

11.12 BRIM Biotechnology Inc

11.12.1 BRIM Biotechnology Inc Company Details

11.12.2 BRIM Biotechnology Inc Business Overview

11.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Introduction

11.12.4 BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2020-2025)

11.12.5 BRIM Biotechnology Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ocular Therapeutix Inc

Sun Pharmaceutical Industries Ltd.

Novartis

SALVAT

AbbVie

Bausch& Lomb Incorporated

BRIM Biotechnology Inc

List of Tables

Table 1. Global Neuropathic Eye Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Steroids

Table 3. Key Players of Antidepressants

Table 4. Key Players of Anticonvulsants

Table 5. Key Players of Opioids

Table 6. Key Players of Others

Table 7. Global Neuropathic Eye Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Neuropathic Eye Pain Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Neuropathic Eye Pain Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Neuropathic Eye Pain Market Share by Region (2020-2025)

Table 11. Global Neuropathic Eye Pain Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Neuropathic Eye Pain Market Share by Region (2026-2031)

Table 13. Neuropathic Eye Pain Market Trends

Table 14. Neuropathic Eye Pain Market Drivers

Table 15. Neuropathic Eye Pain Market Challenges

Table 16. Neuropathic Eye Pain Market Restraints

Table 17. Global Neuropathic Eye Pain Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Neuropathic Eye Pain Market Share by Players (2020-2025)

Table 19. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2024)

Table 20. Ranking of Global Top Neuropathic Eye Pain Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Neuropathic Eye Pain Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Neuropathic Eye Pain, Headquarters and Area Served

Table 23. Global Key Players of Neuropathic Eye Pain, Product and Application

Table 24. Global Key Players of Neuropathic Eye Pain, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Neuropathic Eye Pain Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Neuropathic Eye Pain Revenue Market Share by Type (2020-2025)

Table 28. Global Neuropathic Eye Pain Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Neuropathic Eye Pain Revenue Market Share by Type (2026-2031)

Table 30. Global Neuropathic Eye Pain Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Neuropathic Eye Pain Revenue Market Share by Application (2020-2025)

Table 32. Global Neuropathic Eye Pain Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Neuropathic Eye Pain Revenue Market Share by Application (2026-2031)

Table 34. North America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Neuropathic Eye Pain Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)

Table 49. OKYO Pharma Company Details

Table 50. OKYO Pharma Business Overview

Table 51. OKYO Pharma Neuropathic Eye Pain Product

Table 52. OKYO Pharma Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 53. OKYO Pharma Recent Development

Table 54. Ocular Therapeutix, Inc. Company Details

Table 55. Ocular Therapeutix, Inc. Business Overview

Table 56. Ocular Therapeutix, Inc. Neuropathic Eye Pain Product

Table 57. Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 58. Ocular Therapeutix, Inc. Recent Development

Table 59. IACTA Pharmaceuticals, Inc. Company Details

Table 60. IACTA Pharmaceuticals, Inc. Business Overview

Table 61. IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Product

Table 62. IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 63. IACTA Pharmaceuticals, Inc. Recent Development

Table 64. Sun Pharmaceutical Industries Ltd Company Details

Table 65. Sun Pharmaceutical Industries Ltd Business Overview

Table 66. Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Product

Table 67. Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 68. Sun Pharmaceutical Industries Ltd Recent Development

Table 69. Novartis AG Company Details

Table 70. Novartis AG Business Overview

Table 71. Novartis AG Neuropathic Eye Pain Product

Table 72. Novartis AG Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 73. Novartis AG Recent Development

Table 74. SALVAT Company Details

Table 75. SALVAT Business Overview

Table 76. SALVAT Neuropathic Eye Pain Product

Table 77. SALVAT Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 78. SALVAT Recent Development

Table 79. AbbVie Inc Company Details

Table 80. AbbVie Inc Business Overview

Table 81. AbbVie Inc Neuropathic Eye Pain Product

Table 82. AbbVie Inc Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 83. AbbVie Inc Recent Development

Table 84. Bausch &Lomb Incorporated Company Details

Table 85. Bausch &Lomb Incorporated Business Overview

Table 86. Bausch &Lomb Incorporated Neuropathic Eye Pain Product

Table 87. Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 88. Bausch &Lomb Incorporated Recent Development

Table 89. Kala Pharmaceuticals Company Details

Table 90. Kala Pharmaceuticals Business Overview

Table 91. Kala Pharmaceuticals Neuropathic Eye Pain Product

Table 92. Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 93. Kala Pharmaceuticals Recent Development

Table 94. Spectra Vision Care Company Details

Table 95. Spectra Vision Care Business Overview

Table 96. Spectra Vision Care Neuropathic Eye Pain Product

Table 97. Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 98. Spectra Vision Care Recent Development

Table 99. AlconLaboratories Company Details

Table 100. AlconLaboratories Business Overview

Table 101. AlconLaboratories Neuropathic Eye Pain Product

Table 102. AlconLaboratories Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 103. AlconLaboratories Recent Development

Table 104. BRIM Biotechnology Inc Company Details

Table 105. BRIM Biotechnology Inc Business Overview

Table 106. BRIM Biotechnology Inc Neuropathic Eye Pain Product

Table 107. BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)

Table 108. BRIM Biotechnology Inc Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Neuropathic Eye Pain Picture

Figure 2. Global Neuropathic Eye Pain Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neuropathic Eye Pain Market Share by Type: 2024 VS 2031

Figure 4. Steroids Features

Figure 5. Antidepressants Features

Figure 6. Anticonvulsants Features

Figure 7. Opioids Features

Figure 8. Others Features

Figure 9. Global Neuropathic Eye Pain Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Neuropathic Eye Pain Market Share by Application: 2024 VS 2031

Figure 11. Clinic Case Studies

Figure 12. Hospital Case Studies

Figure 13. Others Case Studies

Figure 14. Neuropathic Eye Pain Report Years Considered

Figure 15. Global Neuropathic Eye Pain Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Neuropathic Eye Pain Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Neuropathic Eye Pain Market Share by Region: 2024 VS 2031

Figure 18. Global Neuropathic Eye Pain Market Share by Players in 2024

Figure 19. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Neuropathic Eye Pain Revenue in 2024

Figure 21. North America Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Neuropathic Eye Pain Market Share by Country (2020-2031)

Figure 23. United States Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Neuropathic Eye Pain Market Share by Country (2020-2031)

Figure 27. Germany Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Neuropathic Eye Pain Market Share by Region (2020-2031)

Figure 35. China Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Neuropathic Eye Pain Market Share by Country (2020-2031)

Figure 43. Mexico Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Neuropathic Eye Pain Market Share by Country (2020-2031)

Figure 47. Turkey Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. OKYO Pharma Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 51. Ocular Therapeutix, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 52. IACTA Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 53. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 54. Novartis AG Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 55. SALVAT Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 56. AbbVie Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 57. Bausch &Lomb Incorporated Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 58. Kala Pharmaceuticals Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 59. Spectra Vision Care Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 60. AlconLaboratories Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 61. BRIM Biotechnology Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13L12609

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32B20021

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38C19846

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2H20253

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions